Compositions for, and methods of, anti-platelet therapy
AssigneeMars, Incorporated
InventorsLeo J. Romanczyk, Jr., Harold H. Schmitz
Life of this patent
Estimating the term…
Abstract
This invention discloses methods of anti-platelet therapy or prophylaxis comprising administering to a subject in need thereof a composition comprising an effective amount of a procyanidin oligomer or a derivative thereof.
Drawings
Claims47
A method of anti-platelet therapy or prophylaxis comprising administering to a subject in need thereof a composition comprising an effective amount of a procyanidin oligomer comprising from 2 to 18 monomeric units of the following formula:
- or a derivative thereof;
- wherein the monomeric units are connected via interflavan linkages 4→6 and/or 4→8, and the subject is a human or a veterinary animal.
A method of anti-platelet therapy or prophylaxis comprising administering to a subject in need thereof a composition comprising an effective amount of a procyanidin oligomer having the formula:
- and n is 0 to 16.
A method of anti-platelet therapy or prophylaxis comprising administering to a subject in need thereof a composition comprising an effective amount of a procyanidin oligomer having the formula:
- wherein A and B are independently oligomers having 1 to 15 monomeric units, and the total number of monomeric units in the procyanidin oligomer is 3 to 18.
Dependencies are inferred from the claim text.